Skip to Main Content
I'm looking for

Table 1: Scope of data extraction from digital wound documentation system for inclusion in the analysis

Wound-related parameters
Types
International Classification of Diseases (ICD-10)
Age at start of treatment
Location
Size
Condition
Exudate
Signs of infection

Dressing-related parameters
Treatment duration
Wear time/interval between dressing changes
Ease of dressing changes
Pain at dressing changes
Results
  • During the evaluation period, 136 patients (52.2% female; 47.8% male) had wounds appropriate for treatment with Mepilex XT; wounds with no exudate were not considered suitable for treatment with the dressing.
  • By week 2, a reduction in wound size was observed from a mean of 11.8cm2 (SD 20.62) at baseline to 6.6cm2 (SD 10.96) at week 2; this reduction in wound size continued into week 4 and week 6 (Figure 1).
  • From baseline to week 6 of treatment, a healing rate of 31% was observed.
  • Mepilex XT dressings were observed to effectively handle wound exudate, irrespective of the quantity, type and/or viscosity.
  • No observation of leakage or maceration was reported throughout the study.
  • Median total treatment duration with the dressing was 39 days (range 7-309 days); during this treatment duration, the median number of dressing changes per week was 3 (range 1-7).
  • At dressing changes, Mepilex XT dressings were found to be easy to remove in over 85% of dressing changes.
  • An overall reduction in pain severity at dressing change from baseline to week 6 was observed (pain data based on 18 patients, as other patients did not experience pain at all at dressing change).

 

Mölnlycke related products

Contact us
Select market

Select your market

Mölnlycke Close

Healthcare Professional Confirmation

The information on the page you are about to enter is intended for healthcare professionals only. By clicking the box below you confirm that you are a healthcare professional.